0
0
0
ALS Placebo No More Act
10/28/2022, 1:46 AM
Congressional Summary of HR 5480
ALS Placebo No More Act
This bill requires the Food and Drug Administration and the National Institutes of Health to collaborate to provide all patients with ALS (amyotrophic lateral sclerosis, also referred to as Lou Gehrig's disease) with access to medicines in clinical trials.
Read the Full Bill
Current Status of Bill HR 5480
Bill HR 5480 is currently in the status of Bill Introduced since December 18, 2019. Bill HR 5480 was introduced during Congress 116 and was introduced to the House on December 18, 2019. Bill HR 5480's most recent activity was Referred to the Subcommittee on Health. as of December 19, 2019
Bipartisan Support of Bill HR 5480
Total Number of Sponsors
1Democrat Sponsors
0Republican Sponsors
1Unaffiliated Sponsors
0Total Number of Cosponsors
3Democrat Cosponsors
0Republican Cosponsors
3Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 5480
Primary Policy Focus
HealthPotential Impact Areas
- Drug safety, medical device, and laboratory regulation
- Drug therapy
- Medical research
- Neurological disorders
Alternate Title(s) of Bill HR 5480
ALS Placebo No More Act
To ensure that ALS patients have access to treatment within clinical trials.
ALS Placebo No More Act
Comments
Sponsors and Cosponsors of HR 5480
Latest Bills
BANNED in Latin America Act
Bill S 4665July 28, 2026
Protecting American Taxpayers Act
Bill S 4952July 28, 2026
Ban Birth Tourism Act of 2026
Bill S 5023July 28, 2026
PEACE in Sudan Act
Bill S 4726July 28, 2026
UNLOCK AUKUS Act
Bill S 4709July 28, 2026
U.S. Tech PATH Act
Bill S 4570July 28, 2026
Iran Human Rights, Internet Freedom, and Accountability Act of 2026
Bill S 3900July 28, 2026
South China Sea Strategy Act of 2026
Bill S 4600July 28, 2026
SAFE Drugs Act of 2026
Bill S 3794July 28, 2026
Eastern Mediterranean Gateway Act
Bill S 4443July 28, 2026